UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 37

Sortiert nach

Impact of physicians' adherence to treat-to-target strategy on outcomes in early rheumatoid arthritis in the NEO-RACo trial

Scandinavian journal of rheumatology, 2015-11, Vol.44 (6), p.449-455

2015

Volltextzugriff (PDF)

Cost of Finnish statutory inpatient rehabilitation and its impact on functional and work capacity of patients with early rheumatoid arthritis: experience from the FIN-RACo trial

Scandinavian journal of rheumatology, 2007-01, Vol.36 (4), p.270-277

2007

Volltextzugriff (PDF)

Comparison of combination therapy with single-drug therapy in early rheumatoid arthritis: a randomised trial

The Lancet (British edition), 1999-05, Vol.353 (9164), p.1568-1573

1999

Volltextzugriff (PDF)

PMS83 - Cost-Effectiveness of Biologics Compared to Conventional Disease-Modifying Antirheumatic Drugs for Treatment of Rheumatoid Arthritis in Finland

Value in health, 2015-11, Vol.18 (7), p.A648-A648

2015

Volltextzugriff (PDF)

Cost-Effectiveness of Biologics Compared to Conventional Disease-Modifying Antirheumatic Drugs for Treatment of Rheumatoid Arthritis in Finland

Value in health, 2015-11, Vol.18 (7), p.A648-A648

2015

Volltextzugriff (PDF)

Development of a novel stability indicating RP-HPLC method for quantification of Connexin43 mimetic peptide and determination of its degradation kinetics in biological fluids

Journal of pharmaceutical analysis, 2017-12, Vol.7 (6), p.365-373

2017

Volltextzugriff (PDF)

Polymeric micelles for ocular drug delivery: From structural frameworks to recent preclinical studies

Journal of controlled release, 2017-02, Vol.248, p.96-116

2017

Volltextzugriff (PDF)

Nanocarrier mediated retinal drug delivery: overcoming ocular barriers to treat posterior eye diseases

Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology, 2018-03, Vol.10 (2), p.e1473-n/a

2018

Volltextzugriff (PDF)

Validation of hyaluronic acid-agar-based hydrogels as vitreous humor mimetics for in vitro drug and particle migration evaluations

European journal of pharmaceutics and biopharmaceutics, 2020-03, Vol.148, p.118-125

2020

Volltextzugriff (PDF)

Nanoparticle-loaded biodegradable light-responsive in situ forming injectable implants for effective peptide delivery to the posterior segment of the eye

Medical hypotheses, 2017-06, Vol.103, p.5-9

2017

Volltextzugriff (PDF)

3-Dimensionally ordered macroporous PEDOT ion-exchange resins prepared by vapor phase polymerization for triggered drug delivery: Fabrication and characterization

Electrochimica acta, 2018-04, Vol.269, p.560-570

2018

Volltextzugriff (PDF)

Infliximab for 6 months added on combination therapy in early rheumatoid arthritis: 2-year results from an investigator-initiated, randomised, double-blind, placebo-controlled study (the NEO-RACo Study)

Annals of the rheumatic diseases, 2013-06, Vol.72 (6), p.851-857

2013

Volltextzugriff (PDF)

ZnO/PVP nanoparticles induce gelation in type I collagen

European polymer journal, 2016-02, Vol.75, p.399-405

2016

Volltextzugriff (PDF)

Ex vivo investigation of ocular tissue distribution following intravitreal administration of connexin43 mimetic peptide using the microdialysis technique and LC-MS/MS

Drug delivery and translational research, 2016-12, Vol.6 (6), p.763-770

2016

Volltextzugriff (PDF)

Preparation and evaluation of PLGA nanoparticle-loaded biodegradable light-responsive injectable implants as a promising platform for intravitreal drug delivery

Journal of drug delivery science and technology, 2017-08, Vol.40, p.142-156

2017

Volltextzugriff (PDF)

Targeted treatment with a combination of traditional DMARDs produces excellent clinical and radiographic long-term outcomes in early rheumatoid arthritis regardless of initial infliximab. The 5-year follow-up results of a randomised clinical trial, the NEO-RACo trial

Annals of the rheumatic diseases, 2014-11, Vol.73 (11), p.1954-1961

2014

Volltextzugriff (PDF)

Results from Enestgoal: A Phase 2 Study of Treatment-Free Remission (TFR) in Patients (pts) with Chronic Myeloid Leukemia in Chronic Phase (CML-CP) Who Switched from Imatinib to Nilotinib

Blood, 2017-12, Vol.130, p.2875-2875

2017

Volltextzugriff (PDF)

Idling for Decades: A European Study on Risk Factors Associated with the Delay Before a Narcolepsy Diagnosis

Nature and science of sleep, 2022-05, Vol.14, p.1031-1047

2022

Volltextzugriff (PDF)

Comparison of Cardiac Troponin I Immunoassays Variably Affected by Circulating Autoantibodies

Clinical chemistry (Baltimore, Md.), 2005-05, Vol.51 (5), p.848-855

2005

Volltextzugriff (PDF)

FATE: the new partnership to Fight Against TB in Central and Eastern Europe

The Lancet infectious diseases, 2017-04, Vol.17 (4), p.363-363

Jagielski, Tomasz

2017

Volltextzugriff (PDF)

ENESTgoal Treatment-Free Remission Study: Updated Preliminary Results and Digital Polymerase Chain Reaction Analysis in Patients with Chronic Myeloid Leukemia in Chronic Phase Who Switched from Imatinib to Nilotinib

Blood, 2016-12, Vol.128 (22), p.3090-3090

2016

Volltextzugriff (PDF)

High burden of adverse events is associated with reduced remission rates in early rheumatoid arthritis

Clinical rheumatology, 2018-06, Vol.37 (6), p.1689-1694

2018

Volltextzugriff (PDF)

Rapid Achievement of MR4.5 after Switching from Imatinib (IM) to Nilotinib (NIL) in Patients (Pts) with Chronic Myeloid Leukemia in Chronic Phase (CML-CP): Preliminary Results from ENESTgoal

Blood, 2015-12, Vol.126 (23), p.4050-4050

2015

Volltextzugriff (PDF)

Cystatin C, NT-proBNP, and inflammatory markers in acute heart failure: insights into the cardiorenal syndrome

Biomarkers, 2011-06, Vol.16 (4), p.302-310

2011

Volltextzugriff (PDF)

Comparative Accuracy of Manual Versus Computerized Electrocardiographic Measurement of J-, ST- and T-Wave Deviations in Patients With Acute Coronary Syndrome

The American journal of cardiology, 2005-12, Vol.96 (11), p.1584-1588

2005

Volltextzugriff (PDF)

1 – 25 von 37

Suche als RSS-Feed

Aktive Filter

ThemaAged

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(29)
Mit Volltextzugriff
(35)

Publikationsform

Sprache

Englisch
(37)

Erscheinungsjahr

n.n

Thema

Science & Technology
(25)
Life Sciences & Biomedicine
(21)
Humans
(11)
Female
(6)
Male
(6)
Ocular Drug Delivery
(6)
Adult
(5)
Middle Aged
(5)
Pharmacology & Pharmacy
(5)
Physical Sciences
(5)
Rheumatology
(5)
Biological And Medical Sciences
(4)
Medical Sciences
(4)
Animals
(3)
Antirheumatic Agents - Therapeutic Use
(3)
Arthritis, Rheumatoid - Drug Therapy
(3)
Double-Blind Method
(3)
Drug Delivery Systems
(3)
Drug Therapy, Combination
(3)
Follow-Up Studies
(3)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Impact of physicians' adherence to treat-to-target strategy on outcomes in early rheumatoid arthritis in the NEO-RACo trial

Cost of Finnish statutory inpatient rehabilitation and its impact on functional and work capacity of patients with early rheumatoid arthritis: experience from the FIN-RACo trial

Comparison of combination therapy with single-drug therapy in early rheumatoid arthritis: a randomised trial

PMS83 - Cost-Effectiveness of Biologics Compared to Conventional Disease-Modifying Antirheumatic Drugs for Treatment of Rheumatoid Arthritis in Finland

Cost-Effectiveness of Biologics Compared to Conventional Disease-Modifying Antirheumatic Drugs for Treatment of Rheumatoid Arthritis in Finland

Development of a novel stability indicating RP-HPLC method for quantification of Connexin43 mimetic peptide and determination of its degradation kinetics in biological fluids

Polymeric micelles for ocular drug delivery: From structural frameworks to recent preclinical studies

Nanocarrier mediated retinal drug delivery: overcoming ocular barriers to treat posterior eye diseases

Validation of hyaluronic acid-agar-based hydrogels as vitreous humor mimetics for in vitro drug and particle migration evaluations

Nanoparticle-loaded biodegradable light-responsive in situ forming injectable implants for effective peptide delivery to the posterior segment of the eye

3-Dimensionally ordered macroporous PEDOT ion-exchange resins prepared by vapor phase polymerization for triggered drug delivery: Fabrication and characterization

Infliximab for 6 months added on combination therapy in early rheumatoid arthritis: 2-year results from an investigator-initiated, randomised, double-blind, placebo-controlled study (the NEO-RACo Study)

ZnO/PVP nanoparticles induce gelation in type I collagen

Ex vivo investigation of ocular tissue distribution following intravitreal administration of connexin43 mimetic peptide using the microdialysis technique and LC-MS/MS

Preparation and evaluation of PLGA nanoparticle-loaded biodegradable light-responsive injectable implants as a promising platform for intravitreal drug delivery

Targeted treatment with a combination of traditional DMARDs produces excellent clinical and radiographic long-term outcomes in early rheumatoid arthritis regardless of initial infliximab. The 5-year follow-up results of a randomised clinical trial, the NEO-RACo trial

Results from Enestgoal: A Phase 2 Study of Treatment-Free Remission (TFR) in Patients (pts) with Chronic Myeloid Leukemia in Chronic Phase (CML-CP) Who Switched from Imatinib to Nilotinib

Idling for Decades: A European Study on Risk Factors Associated with the Delay Before a Narcolepsy Diagnosis

Comparison of Cardiac Troponin I Immunoassays Variably Affected by Circulating Autoantibodies

FATE: the new partnership to Fight Against TB in Central and Eastern Europe

ENESTgoal Treatment-Free Remission Study: Updated Preliminary Results and Digital Polymerase Chain Reaction Analysis in Patients with Chronic Myeloid Leukemia in Chronic Phase Who Switched from Imatinib to Nilotinib

High burden of adverse events is associated with reduced remission rates in early rheumatoid arthritis

Rapid Achievement of MR4.5 after Switching from Imatinib (IM) to Nilotinib (NIL) in Patients (Pts) with Chronic Myeloid Leukemia in Chronic Phase (CML-CP): Preliminary Results from ENESTgoal

Cystatin C, NT-proBNP, and inflammatory markers in acute heart failure: insights into the cardiorenal syndrome

Comparative Accuracy of Manual Versus Computerized Electrocardiographic Measurement of J-, ST- and T-Wave Deviations in Patients With Acute Coronary Syndrome

Aktive Filter

Suchergebnisse filtern